Henric Taavola

ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Venues

Drug safety

British journal of clinical pharmacology

Uppsala Monitoring Centre

Uppsala Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uppsala Monitoring Centre Apr 01 2020

Sweden

Senior Data Scientist :: Research

Uppsala Monitoring Centre Apr 18 2016 - Apr 01 2020

Sweden

Data Scientist :: Research

Uppsala Universitet Dec 01 2009 - Dec 31 2015

Sweden

PhD Student :: Physics and astronomy

Education History

Uppsala Universitet Dec 01 2009 - Dec 31 2015

Sweden

PHD :: Physics and Astronomy

Luleå University of Technology Aug 20 2002 - Nov 19 2009

Sweden

MSC

Publications

Sarah Watson, Elenor Kaminsky, Henric Taavola, Marian Attalla, Qun-Ying Yue
Montelukast and Nightmares: Further Characterisation Using Data from VigiBase. Drug safety 45 (6) (2022)
Corine Ekhart, Florence P A M van Hunsel, Eugene P van Puijenbroek, Rebecca E Chandler, Eva-Lisa Meldau, Henric Taavola, G Niklas Norén
Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports. Drug safety 45 (2) (2022)
Lovisa Sandberg, Henric Taavola, Yasunori Aoki, Rebecca E Chandler, G Niklas Norén
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase. Drug safety 43 (10) (2021)
Eiko Iwasa, Yu Fujiyoshi, Yuki Kubota, Ryota Kimura, Rebecca E Chandler, Henric Taavola, G Niklas Norén, Rika Wakao
Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting. Drug safety 43 (11) (2021)
Rika Wakao, Henric Taavola, Lovisa Sandberg, Eiko Iwasa, Saori Soejima, Rebecca Chandler, G Niklas Norén
Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports. Drug safety 42 (12) (2020)
Ingrid Oosterhuis, Henric Taavola, Philip M Tregunno, Petar Mas, Sara Gama, Victoria Newbould, Ola Caster, Linda Härmark
Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study. Drug safety 41 (10) (2019)
Agnes Kant, Florence P A M van Hunsel, Ola Caster, Henric Taavola, Katka Taxis, Eugene P van Puijenbroek
Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database. British journal of clinical pharmacology 84 (7) (2018)

Henric Taavola.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Henric Taavola